Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.

Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity

Women in assisted reproduction treatment they receive own or donated embryos and presenting an endometrial development less than 5 mm despite having received treatment with estrogen therapy knowing the clinical value of using the PRGF-Endoret therapy and endometrial level applications to improve endometrial thickness endometrial preparations for embryo transfer.

Inclusion Criteria:

• Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.
• Less than 5mm despite 10 days with standard doses of estrogen therapy (6mg / 24h) Endometrio

Exclusion Criteria:

• History of pelvic inflammatory disease
• Risk of infection